VERVE THERAPEUTICS INC shareholders Q3 2023

VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 137 filers reported holding VERVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.

VERVE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CIBC WORLD MARKET INC. 19,048$2530.00%
Citadel Advisors 237,203$3,145,3120.00%
DekaBank Deutsche Girozentrale 50,000$6480.00%
PEAK6 Investments LLC 18,000$238,6800.00%
CARY STREET PARTNERS INVESTMENT ADVISORY LLC 1,000$13,2600.00%
QUADRANT CAPITAL GROUP LLC 192$2,5460.00%
PRICE T ROWE ASSOCIATES INC /MD/ 18,320$2430.00%
NEW YORK STATE COMMON RETIREMENT FUND 23,033$3050.00%
NISA INVESTMENT ADVISORS, LLC 2,780$36,8630.00%
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 14,490$192,1370.00%
AMERIPRISE FINANCIAL INC 62,030$822,5180.00%
DEUTSCHE BANK AG\ 27,705$367,3680.00%
EverSource Wealth Advisors, LLC 79$1,0480.00%
Allworth Financial LP 1$140.00%
Financial Gravity Asset Management, Inc. 1$60.00%
UBS ASSET MANAGEMENT AMERICAS INC 46,592$617,8110.00%
PEAK6 Investments LLC 100$1,3260.00%
CWM, LLC 34$00.00%
MORGAN STANLEY 296,228$3,927,9830.00%
COMERICA BANK 374$4,9590.00%
External links

This page lists VERVE THERAPEUTICS INC's shareholders in Q3 2023. To view VERVE THERAPEUTICS INC's shareholder history, click here.